tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CASI Pharmaceuticals Advances CID-103 in Promising ITP Study
PremiumCompany AnnouncementsCASI Pharmaceuticals Advances CID-103 in Promising ITP Study
1M ago
Casi Pharmaceuticals appoints James Hunag to board of directors
Premium
The Fly
Casi Pharmaceuticals appoints James Hunag to board of directors
2M ago
CASI Pharmaceuticals Strengthens Board with Industry Veteran James Huang
Premium
Company Announcements
CASI Pharmaceuticals Strengthens Board with Industry Veteran James Huang
2M ago
CASI Pharmaceuticals Reports Q2 2025 Results and Strategic Asset Divestiture
PremiumCompany AnnouncementsCASI Pharmaceuticals Reports Q2 2025 Results and Strategic Asset Divestiture
3M ago
CASI Pharmaceuticals Faces Setback with FOLOTYN® License Expiration in China
Premium
Company Announcements
CASI Pharmaceuticals Faces Setback with FOLOTYN® License Expiration in China
3M ago
CASI Pharmaceuticals Receives FDA Clearance for CID-103 IND Application
Premium
Company Announcements
CASI Pharmaceuticals Receives FDA Clearance for CID-103 IND Application
4M ago
CASI Pharmaceuticals Schedules Business Update Amid Legal Proceedings
PremiumCompany AnnouncementsCASI Pharmaceuticals Schedules Business Update Amid Legal Proceedings
7M ago
CASI Pharmaceuticals: Strategic Divestments and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
CASI Pharmaceuticals: Strategic Divestments and Promising Clinical Developments Drive Buy Rating
7M ago
CASI Pharmaceuticals Reports Q1 2025 Results and Asset Divestiture in China
Premium
Company Announcements
CASI Pharmaceuticals Reports Q1 2025 Results and Asset Divestiture in China
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100